Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis

NCT04815902 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Osteoarthritis, Knee

Interventions

DRUG: Fisetin
DRUG: Losartan
DRUG: Placebo - Losartan
DRUG: Placebo Fisetin

Sponsor

Steadman Philippon Research Institute

Collaborators

[object Object]